Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

Antonio Grieco, Nh Afdhal, Eg Giannini, G Tayyab, A Mohsin, J Lee, A Andriulli, L Jeffers, J Mchutchison, P Chen, K Han, F Campbell, D Hyde, A Brainsky, D Theodore

Risultato della ricerca: Contributo in rivistaArticolo in rivista

191 Citazioni (Scopus)


Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure.
Lingua originaleEnglish
pagine (da-a)716-724
Numero di pagine9
RivistaNew England Journal of Medicine
Stato di pubblicazionePubblicato - 2012


  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzoic Acids
  • Chronic Disease
  • Double-Blind Method
  • Female
  • Hemorrhage
  • Humans
  • Hydrazines
  • Liver Cirrhosis
  • Male
  • Middle Aged
  • Platelet Count
  • Platelet Transfusion
  • Pyrazoles
  • Receptors, Thrombopoietin
  • Surgical Procedures, Elective
  • Thrombocytopenia
  • Young Adult


Entra nei temi di ricerca di 'Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia'. Insieme formano una fingerprint unica.

Cita questo